Assessment of patient-reported outcome of patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia and treated with tamsulosin HCl in Korea.

@article{Chang2010AssessmentOP,
  title={Assessment of patient-reported outcome of patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia and treated with tamsulosin HCl in Korea.},
  author={Hyuk Soo Chang and Choal Hee Park and Dae Kyung Kim and Jong Kwan Park and Sung Joon Hong and Byung Ha Chung and Jeong Gu Lee and Choung-soo Kim and Kyu-Sung Lee and Joon Chul Kim},
  journal={Urology},
  year={2010},
  volume={75 5},
  pages={1156-61}
}
OBJECTIVES To evaluate the effect of tamsulosin 0.2 mg once daily in treatment of patients with benign prostatic hyperplasia (BPH) using the new subjective assessment of patient-reported outcomes and the lower urinary tract symptoms (LUTS) outcome score (LOS). METHODS Of 370 patients from 9 urology outpatient clinics, 299 finished this study. Tamsulosin 0.2 mg once daily was administered orally in a nonblind design for a 12-week period. The primary endpoint of this study was to evaluate the… CONTINUE READING